Results for Chemicals & Small Molecules ( 97553 )
Balixafortide TFA (1051366-32-5 free base) (Legacy Tebubio ref. 282TP2141). Balixafortide TFA (POL6326 TFA) is a selective, well-tolerated peptidic CXCR4 antagonist (IC50 < 10 nM). It shows 1000-fold selective for CXCR4 than a large panel of receptors including CXCR7. Balixafortide TFA blocks β-arrestin recruitment and calcium flux (IC50s < 10 nM).
- From: DKK330.00
LSKL TFA (Legacy Tebubio ref. 282TP2147). LSKL TFA (H-Leu-Ser-Lys-Leu-NH2 TFA) is a LAP-TGFβ derivative and a TGF-β1 antagonist that can cross the blood-brain barrier, inhibits the binding of TSP-1 to LAP and reduces renal interstitial fibrosis and liver fibrosis, inhibits subarachnoid fibrosis by inhibiting TSP-1-mediated TGF-β1 activity, prevents the occurrence of chronic hydrocephalus and improves long-term neurocognitive deficits after subarachnoid hemorrhage.
- From: DKK390.00
Ramoplanin (Legacy Tebubio ref. 282TP2152). Ramoplanin is an antibiotic extracted from Actinoplanes spp., a topical lipoglycopeptide antibacterial agent that inhibits gram-positive bacteria by binding to a critical lipid II intermediate, preventing peptidoglycan formation in the cell wall.
- Ref: TP2158Sizes: 1 mg, 5 mg, 25 mg, 100 mg, 50 mg, 10 mg, 200 mg, 1 mL * 10 mM (in DMSO)From: DKK330.00
TRV-120027 TFA (Legacy Tebubio ref. 282TP2158). TRV-120027 TFA is an angiotensin II–mediated vasoconstriction inhibitor and increases cardiomyocyte contractility. TRV-120027 TFA is a β-arrestin-1-biased AT1R agonist engaging ß-arrestins while blocking G-protein signaling[1]. TRV-120027 TFA induces acute catecholamine secretion through cation channel subfamily C3 (TRPC3) coupling and promotes the formation of a macromolecular complex composed of AT1R–β-arrestin-1–TRPC3–PLCγ at the plasma membrane.
- Ref: TP2158L1Sizes: 1 mg, 5 mg, 25 mg, 100 mg, 50 mg, 500 mg, 10 mg